Michelle Hsiang, MD, MS

Title(s)Associate Professor, Epidemiology & Biostatistics
SchoolSchool of Medicine
Address550 16th Street, #3517
San Francisco CA 94158
Phone415-476-2300
ORCID ORCID Icon0000-0003-1217-2742 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stanford University, Stanford, CAB.A.06/2000Human Biology
    Baylor College of Medicine, Houston, TXM.D.05/2005Medicine
    University of California, San Francisco, San Francisco, CAResident06/2008Pediatrics
    University of California, San Francisco, San Francisco, CAFellow06/2012Pediatric Infectious Diseases
    London School of Hygiene and Tropical Medicine, London, UKMSc12/2018Epidemiology
    Collapse Awards and Honors
    UT Southwestern 2014  - 2021Horchow Family Endowed Scholar in Pediatrics
    WomenLift Health, Stanford University and Bill and Melinda Gates Foundation2020  - 2021Woman Leader in Global Health
    UCSF2021  - 2026Chan-Zuckerberg Biohub Investigator Award

    Collapse Overview 
    Collapse Overview
    Dr. Michelle Hsiang aims to improve the health of children through clinical care and the study of malaria. She is Associate Professor in the Epidemiology and Biostatistics, Division of Infectious Diseases and Global Epidemiology, with a secondary appointment in the Department of Pediatrics, Division of Pediatric Infectious Diseases, as well as a Chan-Zuckerburg Biohub Investigator. She serves as the Director of Research for the Malaria Elimination Initiative at the Institute for Global Health Sciences.

    Her research is in the epidemiology of malaria in low-endemic settings aiming for elimination. She develops and evaluates novel malaria diagnostic, surveillance, and drug and vector control interventions to address the challenge of low-level infections that contribute to persistent transmission and disease. She has worked mainly in sub-Saharan Africa but also works in Latin America and the Asia-Pacific.

    She was an inaugural member of the Malaria Elimination Group (MEG) and co-founded the Asia Pacific Malaria Elimination Network (APMEN). She is a WomenLift Leader in Global Health through Stanford and the Bill and Melinda Gates Foundation's program WomenLift Health. She studied Human Biology as an undergraduate at Stanford University and attended medical school at Baylor College of Medicine. She trained in Pediatrics and Pediatric Infectious Diseases at UCSF, and obtained a Masters in Epidemiology at the London School of Hygiene and Tropical Medicine. From 2012-2021, she was Assistant Professor in Pediatrics at UT Southwestern Medical School where she was also a Horchow Family Endowed Scholar in Pediatrics.
    Collapse Global Health Equity

    Collapse Research 
    Collapse Research Activities and Funding
    Focal mass drug administration (fMDA) to reduce Plasmodium vivax transmission, a pragmatic cluster randomized controlled trial in Peru
    NIH/NIAID 1U01AI157962-01A1Aug 10, 2022 - May 31, 2023
    Role: PI
    Description: The goal of this cluster randomized controlled trial is to evaluate the long-term impact and feasibility of focal MDA (fMDA) for Plasmodium vivax transmission reduction.
    Long-term health and socioeconomic impact of interventions targeting low-density malaria infection (LMI) among children in Tanzania
    NIH/NIAID 1U01 AI155315-01A1Apr 15, 2022 - Mar 31, 2023
    Role: PI
    Description: This is a 3-arm open label trial that aims to determine the long-term health and socioeconomic effects of detecting and low-density malaria infection in children.
    Chan Zuckerberg Biohub Investigator Program
    Chan Zuckerberg Biohub Jun 1, 2021 - May 30, 2026
    Description: The CZ Biohub Investigator Program funds research for investigators from UC Berkeley, Stanford University, and UCSF, to pursue risky, exciting ideas. Many of these high-risk projects will involve the invention of new tools and techniques that accelerate the pace of scientific discovery and help CZ Biohub realize its vision of curing, preventing, or managing every disease by the end of the century.
    Insights, President’s Malaria Initiative (PMI) Evaluation & Research-to-Use Implementation Project
    USAID in partnership with PATH AID.574718-01706926-SUBJun 1, 2021 - Sep 30, 2025
    Role: Principal Investigator
    Description: The goal of this project is to design and implement program evaluation and operational research activities in collaboration with in-country research institutions.
    IMPACT Malaria, Operational Research Technical assistance to President's Malaria Initiative supported countries
    USAID in partnership with Population Services International 7200AA18C00014Jun 1, 2021 - Nov 12, 2022
    Role: Principal Investigator
    COVID-19 Pandemic Response and Resilience Initiative in low and middle income countries (LMICs)
    Lampert Byrd Foundation Jul 1, 2020 - Feb 28, 2021
    Role: Principal Investigator
    Achieving Global Malaria Eradication through Accelerated Regional Elimination, Subproject 1.3.1.
    The Bill and Melinda Gates Foundation A128488Jan 1, 2017 - Dec 31, 2021
    Role: Co-Principal Investigator
    Description: The goal was to evaluate the performance of a new highly sensitive rapid diagnostic to detect asymptomatic infections in a low transmission African setting (Namibia).
    Horchow Family Fund for Endowed Scholars in Pediatrics
    UT Southwestern Horchow Family Fund for Endowed Scholars in Pediatrics 5300375400Aug 1, 2014 - Apr 30, 2021
    Role: Principal Investigator
    Description: This scholarship is assigned by the Dean to young and promising investigators. The objective is to support the PI with necessary funds (FTE, supplies, travel, etc.) to support a research program at UT Southwestern.
    Accelerating Progress on Elimination, Project: Targeted Parasite Elimination in Swaziland
    The Bill and Melinda Gates Foundation A122394Jan 1, 2014 - Dec 31, 2018
    Role: Co-Principal Investigator
    Description: The goal of this project was to assess the effectiveness and feasibility of focal mass drug administration for P. falciparum transmission reduction in a cluster randomized controlled trial.
    Eliminating Plasmodium falciparum with ACTs in Namibia.
    Novartis Foundation A122666Jan 1, 2014 - Dec 31, 2017
    Role: Co-Principal Investigator
    Description: The goal of this project was to conduct a cluster randomized controlled trial of targeted MDA.
    Malaria elimination surveillance in Swaziland
    Burroughs Wellcome Fund – ASTMH A120079Jul 1, 2012 - Jun 30, 2017
    Role: Principal Investigator
    Description: The goal of this study was to investigate strategies to improve sensitivity and efficiency for detection of secondary cases in active case detection.
    Evaluating Re-active Surveillance Strategies for Malaria Elimination in Swaziland
    NIH K23AI101012Jun 1, 2012 - May 31, 2019
    Role: Principal Investigator

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Analytical Sensitivity Analysis and Clinical Impact Modeling of Rapigen Rapid Diagnostic Tests for Malaria. Am J Trop Med Hyg. 2024 Sep 03. Golden A, Slater HC, Jang IK, Walke S, Phan TT, Bizilj GT, Rashid A, Barney R, Das S, Rist MJ, McCarthy JS, Nosten F, Landier J, Imwong M, Hume JCC, Sagara I, Healy SA, Duffy PE, Ntuku H, Mumbengegwi D, Hsiang MS, Murphy SC, Rek J, Torres K, Gamboa D, Domingo GJ. PMID: 39226907.
      View in: PubMed   Mentions:
    2. Implementation of Glucose-6-Phosphate Dehydrogenase (G6PD) testing for Plasmodium vivax case management, a mixed method study from Cambodia. PLOS Glob Public Health. 2024; 4(7):e0003476. Cassidy-Seyoum SA, Chheng K, Chanpheakdey P, Meershoek A, Hsiang MS, von Seidlein L, Tripura R, Adhikari B, Ley B, Price RN, Lek D, Engel N, Thriemer K. PMID: 39028699; PMCID: PMC11259306.
      View in: PubMed   Mentions:
    3. Mass drug administration to reduce malaria incidence in a low-to-moderate endemic setting: short-term impact results from a cluster randomised controlled trial in Senegal. medRxiv. 2024 Jul 18. Ba Konko Ciré EH, Roh ME, Diallo A, Gadiaga T, Seck A, Thiam S, Gaye S, Diallo I, Lo AC, Diouf E, Ba OG, Gueye AB, Fogelson A, Wu X, Milligan P, Kibuka T, Hama M, Eckert E, Thwing J, Bennett A, Gosling R, Hwang J, Sene D, Ba F, Cissé B, Sturm-Ramirez K, Hsiang MS, Ndiaye JL. PMID: 39072042; PMCID: PMC11275686.
      View in: PubMed   Mentions:
    4. Child Health and Infection with Low Density (CHILD) malaria: a protocol for a randomised controlled trial to assess the long-term health and socioeconomic impacts of testing and treating low-density malaria infection among children in Tanzania. BMJ Open. 2024 Mar 27; 14(3):e082227. Jebiwott S, Gutapaka N, Sumari D, Loss G, Athuman T, Nyandele JP, Cummins H, Chemba M, Benjamin-Chung J, Gangar P, Wu X, Smith J, Chen I, Dorsey G, Fink G, Olotu A, Hsiang M. PMID: 38538037; PMCID: PMC10982758.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    5. Correction: Testing and treatment for malaria elimination: a systematic review. Malar J. 2024 Mar 01; 23(1):63. Newby G, Cotter C, Roh ME, Harvard K, Bennett A, Hwang J, Chitnis N, Fine S, Stresman G, Chen I, Gosling R, Hsiang MS. PMID: 38429746; PMCID: PMC10908158.
      View in: PubMed   Mentions:    Fields:    
    6. Forest-goers as a heterogeneous population at high-risk for malaria: a case-control study in Aceh Province, Indonesia. Malar J. 2024 Jan 30; 23(1):37. Gallalee S, Zarlinda I, Silaen MG, Cotter C, Cueto C, Elyazar IRF, Jacobson JO, Gosling R, Hsiang MS, Bennett A, Coutrier FN, Smith JL. PMID: 38291392; PMCID: PMC10826189.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Targeted malaria elimination interventions reduce Plasmodium falciparum infections up to 3 kilometers away. medRxiv. 2023 Nov 30. Benjamin-Chung J, Li H, Nguyen A, Heitmann GB, Bennett A, Ntuku H, Prach LM, Tambo M, Wu L, Drakeley C, Gosling R, Mumbengegwi D, Kleinschmidt I, Smith JL, Hubbard A, van der Laan M, Hsiang MS. PMID: 37790419; PMCID: PMC10543053.
      View in: PubMed   Mentions:
    8. Testing and treatment for malaria elimination: a systematic review. Malar J. 2023 Sep 03; 22(1):254. Newby G, Cotter C, Roh ME, Harvard K, Bennett A, Hwang J, Chitnis N, Fine S, Stresman G, Chen I, Gosling R, Hsiang MS. PMID: 37661286; PMCID: PMC10476355.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Assessing the acceptability and feasibility of reactive drug administration for malaria elimination in a Plasmodium vivax predominant setting: a qualitative study in two provinces in Thailand. BMC Public Health. 2023 07 13; 23(1):1346. Suwannarong K, Cotter C, Ponlap T, Bubpa N, Thammasutti K, Chaiwan J, Finn TP, Kitchakarn S, Mårtensson A, Baltzell KA, Hsiang MS, Lertpiriyasuwat C, Sudathip P, Bennett A. PMID: 37438774; PMCID: PMC10339568.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    10. The in-vivo dynamics of Plasmodium falciparum HRP2: implications for the use of rapid diagnostic tests in malaria elimination. Malar J. 2022 Aug 03; 21(1):233. Marquart L, Webb L, O'Rourke P, Gatton ML, Hsiang MS, Kalnoky M, Jang IK, Ntuku H, Mumbengegwi DR, Domingo GJ, McCarthy JS, Britton S. PMID: 35922803; PMCID: PMC9351188.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    11. Application of an innovative grid-based surveillance strategy to ensure elimination and prevent reintroduction of malaria in high-risk border communities in China. BMC Public Health. 2022 07 14; 22(1):1347. Lu SN, Ding W, Wang JZ, Yin SQ, Li SG, Zhou XW, Xu QL, Sun XD, Cotter C, Hsiang MS, Tatarsky A, Gosling R, Lv S, Wang DQ. PMID: 35836156; PMCID: PMC9282898.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Cost and cost effectiveness of reactive case detection (RACD), reactive focal mass drug administration (rfMDA) and reactive focal vector control (RAVC) to reduce malaria in the low endemic setting of Namibia: an analysis alongside a 2×2 factorial design cluster randomised controlled trial. BMJ Open. 2022 06 23; 12(6):e049050. Ntuku H, Smith-Gueye C, Scott V, Njau J, Whittemore B, Zelman B, Tambo M, Prach LM, Wu L, Schrubbe L, Kang Dufour MS, Mwilima A, Uusiku P, Sturrock H, Bennett A, Smith J, Kleinschmidt I, Mumbengegwi D, Gosling R, Hsiang M. PMID: 35738650; PMCID: PMC9226870.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    13. Tafenoquine for the treatment of Plasmodium vivax malaria. Expert Opin Pharmacother. 2022 May; 23(7):759-768. Llanos-Cuentas A, Manrrique P, Rosas-Aguirre A, Herrera S, Hsiang MS. PMID: 35379070.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    14. Triple artemisinin-based combination therapies for malaria: a timely solution to counter antimalarial drug resistance. Lancet Infect Dis. 2022 06; 22(6):751-753. Chen I, Hsiang MS. PMID: 35276063.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    15. Inferring person-to-person networks of Plasmodium falciparum transmission: are analyses of routine surveillance data up to the task? Malar J. 2022 Feb 21; 21(1):58. Huber JH, Hsiang MS, Dlamini N, Murphy M, Vilakati S, Nhlabathi N, Lerch A, Nielsen R, Ntshalintshali N, Greenhouse B, Perkins TA. PMID: 35189905; PMCID: PMC8860266.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsPHPublic Health
    16. Transfusion-Transmitted Malaria: Two Pediatric Cases From the United States and Their Relevance in an Increasingly Globalized World. J Pediatric Infect Dis Soc. 2021 Dec 31; 10(12):1092-1095. Stubbs LA, Price M, Noland D, Fuchs J, Filkins L, McElvania E, Luu HS, Sebert M, Waters A, Hsiang MS. PMID: 34559236; PMCID: PMC8719612.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. Achieving malaria elimination in China. Lancet Public Health. 2021 12; 6(12):e871-e872. Cao J, Newby G, Cotter C, Hsiang MS, Larson E, Tatarsky A, Gosling RD, Xia Z, Gao Q. PMID: 34838192; PMCID: PMC9022785.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    18. Marked reduction in antibiotic usage following intensive malaria control in a cohort of Ugandan children. BMC Med. 2021 11 30; 19(1):294. Krezanoski PJ, Roh ME, Rek J, Nankabirwa JI, Arinaitwe E, Staedke SG, Nayiga S, Hsiang MS, Smith D, Kamya M, Dorsey G. PMID: 34844601; PMCID: PMC8630830.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    19. COVID-19 Therapeutics for Low- and Middle-Income Countries: A Review of Candidate Agents with Potential for Near-Term Use and Impact. Am J Trop Med Hyg. 2021 07 16; 105(3):584-595. Maxwell D, Sanders KC, Sabot O, Hachem A, Llanos-Cuentas A, Olotu A, Gosling R, Cutrell JB, Hsiang MS. PMID: 34270449; PMCID: PMC8592342.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    20. Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial. BMJ Glob Health. 2021 06; 6(6). Vilakati S, Mngadi N, Benjamin-Chung J, Dlamini N, Dufour MK, Whittemore B, Bhangu K, Prach LM, Baltzell K, Nhlabathi N, Malambe C, Dlamini B, Helb D, Greenhouse B, Maphalala G, Pindolia D, Kalungero M, Tesfa G, Gosling R, Ntshalintshali N, Kunene S, Hsiang MS. PMID: 34193475; PMCID: PMC8246301.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    21. Community acceptance of reactive focal mass drug administration and reactive focal vector control using indoor residual spraying, a mixed-methods study in Zambezi region, Namibia. Malar J. 2021 Mar 22; 20(1):162. Roberts KW, Smith Gueye C, Baltzell K, Ntuku H, McCreesh P, Maglior A, Whittemore B, Uusiku P, Mumbengegwi D, Kleinschmidt I, Gosling R, Hsiang MS. PMID: 33752673; PMCID: PMC7986500.
      View in: PubMed   Mentions: 6     Fields:    Translation:PHPublic Health
    22. Mini-outbreak response for malaria using indoor residual spraying. Lancet. 2021 02 27; 397(10276):771-773. Hsiang MS, Mumbengegwi D, Chimumbwa J. PMID: 33640045.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    23. Substantial underestimation of SARS-CoV-2 infection in the United States. Nat Commun. 2020 09 09; 11(1):4507. Wu SL, Mertens AN, Crider YS, Nguyen A, Pokpongkiat NN, Djajadi S, Seth A, Hsiang MS, Colford JM, Reingold A, Arnold BF, Hubbard A, Benjamin-Chung J. PMID: 32908126; PMCID: PMC7481226.
      View in: PubMed   Mentions: 180     Fields:    Translation:HumansCellsPHPublic Health
    24. Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trial. Lancet. 2020 04 25; 395(10233):1361-1373. Hsiang MS, Ntuku H, Roberts KW, Dufour MK, Whittemore B, Tambo M, McCreesh P, Medzihradsky OF, Prach LM, Siloka G, Siame N, Gueye CS, Schrubbe L, Wu L, Scott V, Tessema S, Greenhouse B, Erlank E, Koekemoer LL, Sturrock HJW, Mwilima A, Katokele S, Uusiku P, Bennett A, Smith JL, Kleinschmidt I, Mumbengegwi D, Gosling R. PMID: 32334702; PMCID: PMC7184675.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimalsPHPublic Health
    25. Active Case Finding for Malaria: A 3-Year National Evaluation of Optimal Approaches to Detect Infections and Hotspots Through Reactive Case Detection in the Low-transmission Setting of Eswatini. Clin Infect Dis. 2020 03 17; 70(7):1316-1325. Hsiang MS, Ntshalintshali N, Kang Dufour MS, Dlamini N, Nhlabathi N, Vilakati S, Malambe C, Zulu Z, Maphalala G, Novotny J, Murphy M, Schwartz A, Sturrock H, Gosling R, Dorsey G, Kunene S, Greenhouse B. PMID: 31095677; PMCID: PMC7318780.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    26. "We were afraid of the lion that has roared next to us"; community response to reactive focal mass drug administration for malaria in Eswatini (formerly Swaziland). Malar J. 2019 Jul 15; 18(1):238. Baltzell KA, Maglior A, Bangu K, Mngadi N, Prach LM, Whittemore B, Ntshalintshali N, Saini M, Dlamini N, Kunene S, Hsiang MS. PMID: 31307494; PMCID: PMC6631448.
      View in: PubMed   Mentions: 6     Fields:    Translation:PHPublic Health
    27. Possible canine source of Streptococcus equi subspecies zooepidemicus causing meningitis in an infant. IDCases. 2019; 17:e00568. Zahlanie Y, Almatrafi M, Filkins L, Hsiang MS. PMID: 31194131; PMCID: PMC6555896.
      View in: PubMed   Mentions: 6  
    28. Assessing malaria risk at night-time venues in a low-transmission setting: a time-location sampling study in Zambezi, Namibia. Malar J. 2019 May 22; 18(1):179. Jacobson JO, Smith JL, Cueto C, Chisenga M, Roberts K, Hsiang M, Gosling R, Mumbengegwi D, Bennett A. PMID: 31118028; PMCID: PMC6532237.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsPHPublic Health
    29. Using parasite genetic and human mobility data to infer local and cross-border malaria connectivity in Southern Africa. Elife. 2019 04 02; 8. Tessema S, Wesolowski A, Chen A, Murphy M, Wilheim J, Mupiri AR, Ruktanonchai NW, Alegana VA, Tatem AJ, Tambo M, Didier B, Cohen JM, Bennett A, Sturrock HJ, Gosling R, Hsiang MS, Smith DL, Mumbengegwi DR, Smith JL, Greenhouse B. PMID: 30938286; PMCID: PMC6478435.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansAnimalsPHPublic Health
    30. Subpatent malaria in a low transmission African setting: a cross-sectional study using rapid diagnostic testing (RDT) and loop-mediated isothermal amplification (LAMP) from Zambezi region, Namibia. Malar J. 2018 Dec 19; 17(1):480. McCreesh P, Mumbengegwi D, Roberts K, Tambo M, Smith J, Whittemore B, Kelly G, Moe C, Murphy M, Chisenga M, Greenhouse B, Ntuku H, Kleinschmidt I, Sturrock H, Uusiku P, Gosling R, Bennett A, Hsiang MS. PMID: 30567537; PMCID: PMC6299963.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    31. Laboratory challenges of Plasmodium species identification in Aceh Province, Indonesia, a malaria elimination setting with newly discovered P. knowlesi. PLoS Negl Trop Dis. 2018 11; 12(11):e0006924. Coutrier FN, Tirta YK, Cotter C, Zarlinda I, González IJ, Schwartz A, Maneh C, Marfurt J, Murphy M, Herdiana H, Anstey NM, Greenhouse B, Hsiang MS, Noviyanti R. PMID: 30500828; PMCID: PMC6291163.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsPHPublic Health
    32. Costs and cost-effectiveness of malaria reactive case detection using loop-mediated isothermal amplification compared to microscopy in the low transmission setting of Aceh Province, Indonesia. Malar J. 2018 Jun 01; 17(1):220. Zelman BW, Baral R, Zarlinda I, Coutrier FN, Sanders KC, Cotter C, Herdiana H, Greenhouse B, Shretta R, Gosling RD, Hsiang MS. PMID: 29859081; PMCID: PMC5984760.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    33. Is there a correlation between malaria incidence and IRS coverage in western Zambezi region, Namibia? Public Health Action. 2018 Apr 25; 8(Suppl 1):S44-S49. Mumbengegwi DR, Sturrock H, Hsiang M, Roberts K, Kleinschmidt I, Nghipumbwa M, Uusiku P, Smith J, Bennet A, Kizito W, Takarinda K, Ade S, Gosling R. PMID: 29713594; PMCID: PMC5912422.
      View in: PubMed   Mentions: 9  
    34. Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of Namibia. BMJ Open. 2018 01 27; 8(1):e019294. Medzihradsky OF, Kleinschmidt I, Mumbengegwi D, Roberts KW, McCreesh P, Dufour MK, Uusiku P, Katokele S, Bennett A, Smith J, Sturrock H, Prach LM, Ntuku H, Tambo M, Didier B, Greenhouse B, Gani Z, Aerts A, Gosling R, Hsiang MS. PMID: 29374672; PMCID: PMC5829876.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsPHPublic Health
    35. Reply to Rossi et al. Clin Infect Dis. 2017 10 30; 65(10):1770-1771. Hsiang MS, Ranadive N, Chitundu S, Ntshalintshali N, Greenhouse B. PMID: 29020318; PMCID: PMC5850315.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    36. Limitations of Rapid Diagnostic Testing in Patients with Suspected Malaria: A Diagnostic Accuracy Evaluation from Swaziland, a Low-Endemicity Country Aiming for Malaria Elimination. Clin Infect Dis. 2017 05 01; 64(9):1221-1227. Ranadive N, Kunene S, Darteh S, Ntshalintshali N, Nhlabathi N, Dlamini N, Chitundu S, Saini M, Murphy M, Soble A, Schwartz A, Greenhouse B, Hsiang MS. PMID: 28369268; PMCID: PMC5399938.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimals
    37. Low-Quality Housing Is Associated With Increased Risk of Malaria Infection: A National Population-Based Study From the Low Transmission Setting of Swaziland. Open Forum Infect Dis. 2017; 4(2):ofx071. Dlamini N, Hsiang MS, Ntshalintshali N, Pindolia D, Allen R, Nhlabathi N, Novotny J, Kang Dufour MS, Midekisa A, Gosling R, LeMenach A, Cohen J, Dorsey G, Greenhouse B, Kunene S. PMID: 28580365; PMCID: PMC5447662.
      View in: PubMed   Mentions: 12  
    38. Malaria risk factor assessment using active and passive surveillance data from Aceh Besar, Indonesia, a low endemic, malaria elimination setting with Plasmodium knowlesi, Plasmodium vivax, and Plasmodium falciparum. Malar J. 2016 09 13; 15:468. Herdiana H, Cotter C, Coutrier FN, Zarlinda I, Zelman BW, Tirta YK, Greenhouse B, Gosling RD, Baker P, Whittaker M, Hsiang MS. PMID: 27619000; PMCID: PMC5020529.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimals
    39. Housing quality as a potential risk factor for locally acquired malaria infection in Swaziland. Annals of Global Health. 2016 Aug 20; 82(3):400. Mkhonta MN, Allen AR, Pindolia PD, Ntshalintshali NN, Novotny NJ, Dufour DM, Gosling GR, LeMenach LA, Cohen CJ, Midekisa MA, Greenhouse GB, Hsiang HM, Kunene KS. .
      View in: Publisher Site   Mentions:
    40. Mapping residual transmission for malaria elimination. Elife. 2015 Dec 29; 4. Reiner RC, Le Menach A, Kunene S, Ntshalintshali N, Hsiang MS, Perkins TA, Greenhouse B, Tatem AJ, Cohen JM, Smith DL. PMID: 26714110; PMCID: PMC4744184.
      View in: PubMed   Mentions: 40     Fields:    Translation:PHPublic Health
    41. Epidemiology of community-associated methicillin-resistant Staphylococcus aureus in San Francisco children. Journal of Pediatric Infectious Diseases. 2015 Jul 28; 4(3):247-259. Hermos HC, Shiau SR, Hsiang HM, Chambers CH, Pan PE. .
      View in: Publisher Site   Mentions:
    42. Striding Toward Malaria Elimination in China. Am J Trop Med Hyg. 2015 Aug; 93(2):203-204. Hsiang MS, Gosling RD. PMID: 26078325; PMCID: PMC4530732.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    43. Reply to Goyal et al. J Infect Dis. 2015 May 15; 211(10):1687. Hsiang MS, Greenhouse B, Rosenthal PJ. PMID: 25512627; PMCID: PMC4407763.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    44. Fine-scale malaria risk mapping from routine aggregated case data. Malar J. 2014 Nov 03; 13:421. Sturrock HJ, Cohen JM, Keil P, Tatem AJ, Le Menach A, Ntshalintshali NE, Hsiang MS, Gosling RD. PMID: 25366929; PMCID: PMC4349235.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    45. Point of care testing for malaria using LAMP, loop mediated isothermal amplification. J Infect Dis. 2014 Oct 15; 210(8):1167-9. Hsiang MS, Greenhouse B, Rosenthal PJ. PMID: 24795471.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    46. Malaria in overseas labourers returning to China: an analysis of imported malaria in Jiangsu Province, 2001-2011. Malar J. 2014 Jan 25; 13:29. Liu Y, Hsiang MS, Zhou H, Wang W, Cao Y, Gosling RD, Cao J, Gao Q. PMID: 24460982; PMCID: PMC3922785.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansAnimals
    47. Pulmonary coccidiomycosis masquerading as refractory metastatic Ewing sarcoma. J Pediatr Hematol Oncol. 2014 Jan; 36(1):e57-60. Stieglitz E, Hsiang MS, Simko JP, Hirose S, Goldsby RE. PMID: 23588326.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    48. Malaria and severe anemia: thinking beyond Plasmodium falciparum. PLoS Med. 2013 Dec; 10(12):e1001576. Gosling RD, Hsiang MS. PMID: 24358032; PMCID: PMC3866086.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    49. Mass drug administration for the control and elimination of Plasmodium vivax malaria: an ecological study from Jiangsu province, China. Malar J. 2013 Nov 01; 12:383. Hsiang MS, Hwang J, Tao AR, Liu Y, Bennett A, Shanks GD, Cao J, Kachur SP, Feachem RG, Gosling RD, Gao Q. PMID: 24175930; PMCID: PMC3842644.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansPHPublic Health
    50. Active case detection for malaria elimination: a survey among Asia Pacific countries. Malar J. 2013 Oct 09; 12:358. Smith Gueye C, Sanders KC, Galappaththy GN, Rundi C, Tobgay T, Sovannaroth S, Gao Q, Surya A, Thakur GD, Baquilod M, Lee WJ, Bobogare A, Deniyage SL, Satimai W, Taleo G, Hung NM, Cotter C, Hsiang MS, Vestergaard LS, Gosling RD. PMID: 24103345; PMCID: PMC3852840.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansPHPublic Health
    51. Targeting asymptomatic malaria infections: active surveillance in control and elimination. PLoS Med. 2013; 10(6):e1001467. Sturrock HJ, Hsiang MS, Cohen JM, Smith DL, Greenhouse B, Bousema T, Gosling RD. PMID: 23853551; PMCID: PMC3708701.
      View in: PubMed   Mentions: 218     Fields:    Translation:HumansPHPublic Health
    52. Reactive case detection for malaria elimination: real-life experience from an ongoing program in Swaziland. PLoS One. 2013; 8(5):e63830. Sturrock HJ, Novotny JM, Kunene S, Dlamini S, Zulu Z, Cohen JM, Hsiang MS, Greenhouse B, Gosling RD. PMID: 23700437; PMCID: PMC3658965.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansPHPublic Health
    53. The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet. 2013 Sep 07; 382(9895):900-11. Cotter C, Sturrock HJ, Hsiang MS, Liu J, Phillips AA, Hwang J, Gueye CS, Fullman N, Gosling RD, Feachem RG. PMID: 23594387; PMCID: PMC10583787.
      View in: PubMed   Mentions: 360     Fields:    Translation:HumansAnimals
    54. Prevalence of PCR detectable malaria infection among febrile patients with a negative Plasmodium falciparum specific rapid diagnostic test in Zanzibar. Am J Trop Med Hyg. 2013 Feb; 88(2):289-91. Baltzell KA, Shakely D, Hsiang M, Kemere J, Ali AS, Björkman A, Mårtensson A, Omar R, Elfving K, Msellem M, Aydin-Schmidt B, Rosenthal PJ, Greenhouse B. PMID: 23249688; PMCID: PMC3583319.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimals
    55. Rationale for short course primaquine in Africa to interrupt malaria transmission. Malar J. 2012 Oct 30; 11:360. Eziefula AC, Gosling R, Hwang J, Hsiang MS, Bousema T, von Seidlein L, Drakeley C, Primaquine in Africa Discussion Group. PMID: 23130957; PMCID: PMC3502539.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansPHPublic Health
    56. Epidemiologic Similarities in Pediatric Community-Associated Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus in the San Francisco Bay Area. J Pediatric Infect Dis Soc. 2012 Sep; 1(3):200-11. Hsiang MS, Shiau R, Nadle J, Chan L, Lee B, Chambers HF, Pan E. PMID: 23687577; PMCID: PMC3656541.
      View in: PubMed   Mentions: 10     Fields:    
    57. Surveillance for malaria elimination in Swaziland: a national cross-sectional study using pooled PCR and serology. PLoS One. 2012; 7(1):e29550. Hsiang MS, Hwang J, Kunene S, Drakeley C, Kandula D, Novotny J, Parizo J, Jensen T, Tong M, Kemere J, Dlamini S, Moonen B, Angov E, Dutta S, Ockenhouse C, Dorsey G, Greenhouse B. PMID: 22238621; PMCID: PMC3253098.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansPHPublic Health
    58. Journal of Pediatric Infectious Diseases Society. Few Factors Distinguish Pediatric Community-Associated Methicillin-Resistant from Methicillin-Sensitive Staphylococcus aureus Infections: a Case Comparison Study in San Francisco Bay Area. 2012; 1(30):200-211. Hsiang MS, Shiau R, Nadle J, Chan L, Lee B, Chambers HF, Pan E.
    59. Trends in malaria research in 11 Asian Pacific countries: an analysis of peer-reviewed publications over two decades. Malar J. 2011 May 18; 10:131. Andersen F, Douglas NM, Bustos D, Galappaththy G, Qi G, Hsiang MS, Kusriastuti R, Mendis K, Taleo G, Whittaker M, Price RN, von Seidlein L. PMID: 21586174; PMCID: PMC3118956.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    60. Costs and financial feasibility of malaria elimination. Lancet. 2010 Nov 06; 376(9752):1604-15. Sabot O, Cohen JM, Hsiang MS, Kahn JG, Basu S, Tang L, Zheng B, Gao Q, Zou L, Tatarsky A, Aboobakar S, Usas J, Barrett S, Cohen JL, Jamison DT, Feachem RG. PMID: 21035839; PMCID: PMC3044845.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    61. PCR-based pooling of dried blood spots for detection of malaria parasites: optimization and application to a cohort of Ugandan children. J Clin Microbiol. 2010 Oct; 48(10):3539-43. Hsiang MS, Lin M, Dokomajilar C, Kemere J, Pilcher CD, Dorsey G, Greenhouse B. PMID: 20686079; PMCID: PMC2953134.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    62. The impact of Schistosoma japonicum infection and treatment on ultrasound-detectable morbidity: a five-year cohort study in Southwest China. PLoS Negl Trop Dis. 2010 May 18; 4(5):e685. Carlton EJ, Hsiang M, Zhang Y, Johnson S, Hubbard A, Spear RC. PMID: 20502515; PMCID: PMC2872638.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    63. Malaria elimination in Asia-Pacific: an under-told story. Lancet. 2010 May 08; 375(9726):1586-7. Hsiang MS, Abeyasinghe R, Whittaker M, Feachem RG. PMID: 20452505.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    64. Use of ultrasonography to evaluate Schistosoma japonicum-related morbidity in children, Sichuan Province, China, 2000-2007. Am J Trop Med Hyg. 2010 Jan; 82(1):103-11. Hsiang MS, Carlton EJ, Zhang Y, Zhong B, Dongchuan Q, Cohen PA, Stewart CC, Spear RC. PMID: 20065003; PMCID: PMC2803517.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    65. High Prevalence of Risk Factors among Pediatric Patients with Community-Associated Methicillin Resistant Staphylococcus aureus in San Francisco. Journal of Pediatric Infectious Diseases. 2009; 3(4). Hermos C, Shiau R, Hsiang M, Chambers HF, Pan E.
    Michelle's Networks
    Concepts (182)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (34)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.